会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • 4-amino-3-acylnaphthyridine derivatives
    • 4-氨基-3-酰基萘啶衍生物
    • US5952504A
    • 1999-09-14
    • US849740
    • 1997-07-03
    • Han Yong YooKae Jong ChungMan Sik ChangSung Gyu KimWahn Soo ChoiDae Pil KangYoung Hun KimJang Hoon PaekSang Kwon SohnBog Goo KangYoung Heui KimKwi Hyon Seo
    • Han Yong YooKae Jong ChungMan Sik ChangSung Gyu KimWahn Soo ChoiDae Pil KangYoung Hun KimJang Hoon PaekSang Kwon SohnBog Goo KangYoung Heui KimKwi Hyon Seo
    • A61K31/435A61K31/4375A61P1/04A61P35/00C07D471/04
    • C07D471/04
    • Novel 4-amino-3-acylnaphthyridine derivatives represented by formula (I), wherein R.sub.1 is hydrogen, C.sub.1 -C.sub.6 lower alkyl group, C.sub.1 -C.sub.6 lower alkoxy group, C.sub.1 -C.sub.6 lower alkoxyalkyl group, C.sub.3 -C.sub.6 cycloalkyl group, C.sub.3 -C.sub.6 cycloalkyl C.sub.1 -C.sub.6 alkyl group, a or phenyl group which maybe substituted with C.sub.1 -C.sub.6 alkyl group; R.sub.2 is hydrogen, C.sub.1 -C.sub.6 lower alkyl group, C.sub.1 -C.sub.6 alkoxy group, C.sub.1 -C.sub.6 alkylthio group, or a group of the formula: NR.sub.6 R.sub.7 wherein R.sub.6 and R.sub.7, identical to or different from each other, are independently hydrogen or C.sub.1 -C.sub.6 lower alkyl group, or R.sub.6 and R.sub.7 may form together 5-membered or 6-membered cycloalkyl group; R.sub.3 is hydrogen, C.sub.1 -C.sub.6 lower alkyl group, C.sub.1 -C.sub.6 alkoxy group, C.sub.1 -C.sub.6 alkylthio group, an amino group substituted with one or two C.sub.1 -C.sub.6 alkyl groups, halogen, cyano group, C.sub.1 -C.sub.6 alkanoyl group, or trifluoromethyl group; R.sub.4 is hydrogen or a substituted or unsubstituted C.sub.1 -C.sub.6 alkyl group; R.sub.5 is hydrogen atom, C.sub.1 -C.sub.6 lower alkyl group, C.sub.1 -C.sub.6 alkoxy group, amino group substituted with one or two C.sub.1 -C.sub.6 alkyl groups, C.sub.1 -C.sub.6 alkylthio group, halogen, cyano group, hydroxycarbamoyl group, carboxy group, a C.sub.1 -C.sub.6 alkanoyl group, or trifluoromethyl group, or alkyl group which forms together with R.sub.4 a 5-membered or 6-membered cycloalkyl group; m is an integer from 0 to 4, inclusive; and n is an integer from 1 to 3 inclusive; with the proviso that all alkyl and alkoxy groups may be linear or branched, and said halogen means fluorine, chlorine or bromine atom, or a pharmaceutically acceptable salt therefore. These compounds show excellent anti-ulcer activity.
    • PCT No.PCT / KR96 / 00080 Sec。 371日期1997年7月3日 102(e)日期1997年7月3日PCT PCT 1996年6月1日PCT公布。 公开号WO97 / 03074 日期1997年1月30日由式(I)表示的新型4-氨基-3-酰基萘啶衍生物,其中R1为氢,C1-C6低级烷基,C1-C6低级烷氧基,C1-C6低级烷氧基烷基,C3-C6 环烷基,C3-C6环烷基C1-C6烷基,或可被C1-C6烷基取代的苯基; R 2是氢,C 1 -C 6低级烷基,C 1 -C 6烷氧基,C 1 -C 6烷硫基或下式的基团:NR 6 R 7其中R 6和R 7彼此相同或不同,独立地为氢或C1- C6低级烷基,或R6和R7可以一起形成5元或6元环烷基; R3是氢,C1-C6低级烷基,C1-C6烷氧基,C1-C6烷硫基,被一个或两个C1-C6烷基取代的氨基,卤素,氰基,C1-C6烷酰基或三氟甲基 组; R4是氢或取代或未取代的C1-C6烷基; R5是氢原子,C1-C6低级烷基,C1-C6烷氧基,被一个或两个C1-C6烷基取代的氨基,C1-C6烷硫基,卤素,氰基,羟基氨基甲酰基,羧基,C1 -C 6烷酰基或三氟甲基,或与R 4一起形成5元或6元环烷基的烷基; m为0〜4的整数,包括0和4; n为1〜3的整数, 条件是所有烷基和烷氧基可以是直链或支链的,并且所述卤素是指氟,氯或溴原子,或其药学上可接受的盐。 这些化合物显示出优异的抗溃疡活性。